Gabriele Murineddu

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Topics

Neoadjuvant Chemotherapy

Structural Basis

Molecular Docking

Respiratory Syncytial Virus

Top Venues

Molecules (Basel, Switzerland)

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Stefano Zoroddu, Luca Sanna, Valentina Bordoni, Weidong Lyu, Gabriele Murineddu, Gerard A Pinna, Sonia Vanina Forcales, Arturo Sala, David J Kelvin, Luigi Bagella
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines. International journal of molecular sciences 24 (14) (2023)
Sandra Piras, Gabriele Murineddu, Giovanni Loriga, Antonio Carta, Enrica Battistello, Stefania Merighi, Stefania Gessi, Paola Corona, Battistina Asproni, Roberta Ibba, Veronika Temml, Daniela Schuster, Gérard Aimè Pinna
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. Molecules (Basel, Switzerland) 26 (18) (2021)
Battistina Asproni, Gabriele Murineddu, Paola Corona, Gérard A Pinna
Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB1/CB2 Receptor Interaction. Molecules (Basel, Switzerland) 26 (8) (2021)
Giuseppina Sanna, Sandra Piras, Silvia Madeddu, Bernardetta Busonera, Boris Klempa, Paola Corona, Roberta Ibba, Gabriele Murineddu, Antonio Carta, Roberta Loddo
5,6-Dichloro-2-phenyl-benzotriazoles: New Potent Inhibitors of Orthohantavirus. Viruses 12 (1) (2020)
Gabriele Murineddu, Battistina Asproni, Paola Corona, Sandra Piras, Paolo Lazzari, Stefania Ruiu, Laura Legnani, Lucio Toma, Gérard A Pinna
Development of Oxygen-Bridged Pyrazole-Based Structures as Cannabinoid Receptor 1 Ligands. Molecules (Basel, Switzerland) 24 (9) (2019)
Giulio Ragusa, Serena Bencivenni, Paula Morales, Tyra Callaway, Dow P Hurst, Battistina Asproni, Stefania Merighi, Giovanni Loriga, Gerard A Pinna, Patricia H Reggio, Stefania Gessi, Gabriele Murineddu
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands. ChemMedChem 13 (11) (2018)
Battistina Asproni, Ilaria Manca, Giansalvo Pinna, Elena Cichero, Paola Fossa, Gabriele Murineddu, Paolo Lazzari, Giovanni Loriga, Gérard A Pinna
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands. Chemical biology & drug design 91 (1) (2017)